BG101067A - Sterol derivatives used for meiosis regulation - Google Patents
Sterol derivatives used for meiosis regulationInfo
- Publication number
- BG101067A BG101067A BG101067A BG10106796A BG101067A BG 101067 A BG101067 A BG 101067A BG 101067 A BG101067 A BG 101067A BG 10106796 A BG10106796 A BG 10106796A BG 101067 A BG101067 A BG 101067A
- Authority
- BG
- Bulgaria
- Prior art keywords
- sterol derivatives
- derivatives used
- meiosis
- regulation
- sterols
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/001—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class spiro-linked
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK75394 | 1994-06-23 | ||
| DK24195 | 1995-03-09 | ||
| PCT/DK1995/000265 WO1996000235A1 (fr) | 1994-06-23 | 1995-06-23 | Derives du type sterol utilises pour reguler la meiose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG101067A true BG101067A (en) | 1997-08-29 |
Family
ID=26063596
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG101067A BG101067A (en) | 1994-06-23 | 1996-12-18 | Sterol derivatives used for meiosis regulation |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US5716777A (fr) |
| EP (1) | EP0767798B1 (fr) |
| JP (1) | JP3987105B2 (fr) |
| KR (1) | KR100408369B1 (fr) |
| CN (1) | CN1068333C (fr) |
| AT (1) | ATE248852T1 (fr) |
| AU (1) | AU694240B2 (fr) |
| BG (1) | BG101067A (fr) |
| BR (1) | BR9508074A (fr) |
| CA (1) | CA2192941C (fr) |
| CZ (1) | CZ289407B6 (fr) |
| DE (1) | DE69531682T2 (fr) |
| DK (1) | DK0767798T3 (fr) |
| ES (1) | ES2204955T3 (fr) |
| FI (1) | FI117159B (fr) |
| HU (1) | HUT76343A (fr) |
| IL (1) | IL114294A (fr) |
| IS (1) | IS4404A (fr) |
| MX (1) | MX9700174A (fr) |
| NO (1) | NO314534B1 (fr) |
| PL (1) | PL186688B1 (fr) |
| RU (1) | RU2194510C2 (fr) |
| SI (1) | SI9520077A (fr) |
| SK (1) | SK165596A3 (fr) |
| UA (1) | UA51622C2 (fr) |
| WO (1) | WO1996000235A1 (fr) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP9800731A3 (en) * | 1995-03-06 | 2000-03-28 | Novo Nordisk As | Stimulation of meiosis |
| CA2224866A1 (fr) * | 1995-06-23 | 1997-01-09 | Novo Nordisk A/S | Composes regulateurs de la meiose |
| AU6122696A (en) * | 1995-06-23 | 1997-01-22 | Novo Nordisk A/S | Meiosis regulating compounds |
| US6645953B2 (en) * | 1995-06-23 | 2003-11-11 | Novo Nordisk A/S | Meiosis regulating compounds |
| JP2001506656A (ja) | 1996-12-20 | 2001-05-22 | ノボ ノルディスク アクティーゼルスカブ | 減数分裂調節化合物 |
| WO1998052965A1 (fr) * | 1997-05-16 | 1998-11-26 | Akzo Nobel N.V. | DERIVES DE 20-ARALKYL-5α-PREGNANE |
| TR199902873T2 (xx) * | 1997-06-04 | 2000-04-21 | Akzo Nobel N.V. | Miyozun mod�lasyonu i�in 17�-aliloksi(tiyo)alkil-androstan t�revleri. |
| JP2001526293A (ja) * | 1997-12-18 | 2001-12-18 | アクゾ・ノベル・エヌ・ベー | 17β−アリール(アリールメチル)オキシ(チオ)アルキル−アンドロスタン誘導体 |
| WO1999058549A1 (fr) * | 1998-05-13 | 1999-11-18 | Novo Nordisk A/S | Composes regulateurs de la meiose |
| KR20010043558A (ko) | 1998-05-13 | 2001-05-25 | 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 | 감수분열 조절 화합물 |
| EP1098652A2 (fr) * | 1998-05-26 | 2001-05-16 | Schering Aktiengesellschaft | Traitement de l'infertilite par des composes stimulant la production d'ampc, seuls ou associes a au moins un compose stimulant la meiose |
| IL140216A0 (en) * | 1998-06-19 | 2002-02-10 | Novo Nordisk As | Meiosis regulating compounds |
| US6528501B1 (en) * | 1998-12-11 | 2003-03-04 | Akzo Nobel N.V. | 22s-hydroxycholesta-8, 14-diene derivatives with meiosis regulating activity |
| AU3118200A (en) | 1998-12-14 | 2000-07-03 | Merck & Co., Inc. | Hiv integrase inhibitors |
| CZ20012866A3 (cs) * | 1999-02-10 | 2002-01-16 | Schering Aktiengesellschaft | Nenasycené cholestanové deriváty, farmaceutické kompozice obsahující tyto deriváty a pouľití těchto derivátů pro přípravu léčiv regulujících meiozu |
| CN1353617A (zh) * | 1999-02-24 | 2002-06-12 | 诺沃挪第克公司 | 不孕症的治疗 |
| AU2794000A (en) * | 1999-02-24 | 2000-09-14 | Novo Nordisk A/S | Treatment of infertility |
| CZ20012671A3 (cs) * | 1999-02-26 | 2002-01-16 | Novo Nordisk A/S | Způsob in vitro oplodnění s pouľitím kultivačního média obsahujícího sterol aktivující meiosu |
| WO2000053618A1 (fr) * | 1999-03-09 | 2000-09-14 | Akzo Nobel N.V. | Derives de 22r-hydroxycholesta-8,14-diene a activite d'inhibition de la meiose |
| CA2382908A1 (fr) * | 1999-09-16 | 2001-03-22 | Novo Nordisk A/S | Composition pour fecondation in vitro |
| EP1127890A1 (fr) | 2000-02-22 | 2001-08-29 | Schering Aktiengesellschaft | Stéroides avec un cycle condensés au cycle A du noyau stéroide pour la régulation de la méiose |
| MXPA02007818A (es) * | 2000-02-25 | 2002-10-23 | Schering Ag | Tasa de implantacion mejorada utilizando ff-mas. |
| WO2001062260A2 (fr) * | 2000-02-25 | 2001-08-30 | Schering Aktiengesellschaft | Amelioration d'un taux d'implantation |
| MXPA02011271A (es) * | 2000-05-18 | 2003-04-25 | Schering Ag | Fertilizacion de oocitos envejecidos. |
| EP1245572A1 (fr) | 2001-03-26 | 2002-10-02 | Schering Aktiengesellschaft | Composés aminostérols, leur utilisation pour la préparation des médicaments pour la régulation de la méiose et un procédé de leur préparation |
| WO2003070766A2 (fr) * | 2002-02-22 | 2003-08-28 | Novo Nordisk A/S | Transducteur de la signalisation de mas |
| WO2012044817A2 (fr) * | 2010-10-01 | 2012-04-05 | Indiana University Research And Technology Corporation | Procédé de préparation de stéroïdes delta-7,9(11) à partir de ganoderma lucidum et d'analogues de ceux-ci |
| US9165822B2 (en) | 2013-03-11 | 2015-10-20 | Taiwan Semiconductor Manufacturing Company, Ltd. | Semiconductor devices and methods of forming same |
| EA024619B1 (ru) * | 2014-11-21 | 2016-10-31 | Эльвин Гаджи оглы Керимли | ФРАКСИНОСТЕРИН - 24β-ЭТИЛХОЛЕСТА-20-КАРБОКСИ-6(7),8(9)-ДИЕН 3β-ОЛА И ЕГО ПРОИЗВОДНОЕ |
-
1995
- 1995-05-23 US US08/448,217 patent/US5716777A/en not_active Expired - Fee Related
- 1995-06-23 KR KR1019960707361A patent/KR100408369B1/ko not_active Expired - Fee Related
- 1995-06-23 SK SK1655-96A patent/SK165596A3/sk unknown
- 1995-06-23 EP EP95922448A patent/EP0767798B1/fr not_active Expired - Lifetime
- 1995-06-23 PL PL95317830A patent/PL186688B1/pl not_active IP Right Cessation
- 1995-06-23 MX MX9700174A patent/MX9700174A/es not_active IP Right Cessation
- 1995-06-23 JP JP50272496A patent/JP3987105B2/ja not_active Expired - Lifetime
- 1995-06-23 CA CA002192941A patent/CA2192941C/fr not_active Expired - Fee Related
- 1995-06-23 ES ES95922448T patent/ES2204955T3/es not_active Expired - Lifetime
- 1995-06-23 AU AU27343/95A patent/AU694240B2/en not_active Ceased
- 1995-06-23 UA UA96124771A patent/UA51622C2/uk unknown
- 1995-06-23 HU HU9603584A patent/HUT76343A/hu not_active Application Discontinuation
- 1995-06-23 BR BR9508074A patent/BR9508074A/pt not_active IP Right Cessation
- 1995-06-23 AT AT95922448T patent/ATE248852T1/de not_active IP Right Cessation
- 1995-06-23 CN CN95193731A patent/CN1068333C/zh not_active Expired - Fee Related
- 1995-06-23 DE DE69531682T patent/DE69531682T2/de not_active Expired - Fee Related
- 1995-06-23 DK DK95922448T patent/DK0767798T3/da active
- 1995-06-23 CZ CZ19963725A patent/CZ289407B6/cs not_active IP Right Cessation
- 1995-06-23 IL IL11429495A patent/IL114294A/en not_active IP Right Cessation
- 1995-06-23 RU RU97101087/14A patent/RU2194510C2/ru not_active IP Right Cessation
- 1995-06-23 SI SI9520077A patent/SI9520077A/sl unknown
- 1995-06-23 WO PCT/DK1995/000265 patent/WO1996000235A1/fr not_active Ceased
-
1996
- 1996-12-18 BG BG101067A patent/BG101067A/xx unknown
- 1996-12-20 NO NO19965516A patent/NO314534B1/no unknown
- 1996-12-20 FI FI965144A patent/FI117159B/fi active IP Right Grant
- 1996-12-23 IS IS4404A patent/IS4404A/is unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG101067A (en) | Sterol derivatives used for meiosis regulation | |
| IL130249A0 (en) | Meiosis regulating compounds | |
| GEP20012530B (en) | Neuroactive Steroids of the Androstane and Pregnane Series | |
| GR3034204T3 (en) | Lipopolyamines as transfection agents and pharmaceutical uses thereof | |
| ATE215081T1 (de) | Gonadotropin releasing hormon- antagonisten | |
| MD1616F2 (en) | Tricyclic compounds and method of inhibiting the tyrasin kinases receptors of the epidermal growth factor, pharmaceutical composition, methods of preventing the blastocites implantation and mammals treatment | |
| LV12438A (en) | Metode of preventing and delyaing the onset of alzheimer's disease and composition thereof | |
| NZ325060A (en) | Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone | |
| DE69533991D1 (de) | Dipeptide, die die ausschüttung von wachstumshormonen stimulieren | |
| PL309225A1 (en) | Pharmacologically active derivatives of pyridine and methods of obtaining them | |
| AU5648496A (en) | Pyrazolo-(1,5a)pyrimidines, their preparation and their use | |
| MY115211A (en) | Novel amino acid derivatives, their preparation and use | |
| NZ300942A (en) | 1-aryl-2-acylamino-ethane derivatives as neurokinin 1 antagonists | |
| IL111862A0 (en) | N-substituted azabicycloheptane derivatives | |
| AU3116295A (en) | N-substituted 3-azabicyclo (3.2.0)heptane derivatives, the preparation and use thereof | |
| PL344155A1 (en) | Meiosis regulating compounds | |
| MX9803662A (es) | Oligopeptidos novedosos, preparacion y uso de estos. | |
| MX9800123A (es) | Compuestos que regulan la meiosis. | |
| PL311296A1 (en) | Derivatives of benzo [f] quinoxalinodione, method of obtaining them and their application in therapeutic agents | |
| BR9713762A (pt) | Composto, uso dos mesmos, e, processo para regular a meiose em uma célula germinativa de mamìfero. | |
| AU6829396A (en) | Compositions and their uses | |
| MY129421A (en) | INHIBITORS OF p38 |